117 results on '"Penson, Peter E."'
Search Results
2. Patient experiences of their current asthma care and their views toward providing support for patients with asthma in community pharmacy: A Qualitative study
3. Supermarket/hypermarket opportunistic screening for atrial fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study
4. Using Read-Across to build Physiologically-Based Kinetic models: Part 2. Case studies for atenolol and flumioxazin
5. Using read-across to build physiologically-based kinetic models: Part 1. Development of a KNIME workflow to assist analogue selection for PBK modelling
6. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
7. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
8. Integrated Care for Atrial Fibrillation Management: The Role of the Pharmacist
9. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis
10. Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
11. Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study
12. The management of asthma in adult patients in the community pharmacy setting: Literature review
13. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry
14. Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes
15. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
16. A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome
17. Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003–18.
18. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis.
19. Managing older people with atrial fibrillation and preventing stroke: a review of anticoagulation approaches.
20. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies.
21. Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies.
22. The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.
23. Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study.
24. Lecturing: A lost art
25. Identifying and addressing pill aversion in adults without physiological‐related dysphagia: A narrative review.
26. Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018.
27. Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022).
28. 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy.
29. Prevalence of statin intolerance: a meta-analysis.
30. Activation of β-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction
31. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
32. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta‐analysis of randomized controlled trials.
33. Warfarin—Is Self-Care the Best Care?
34. Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study Protocol.
35. Individualized therapy in statin intolerance: the key to success.
36. Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress.
37. RNA Silencing in the Management of Dyslipidemias.
38. Vasopressors for cardiopulmonary resuscitation Does pharmacological evidence support clinical practice?
39. Effects of hypoxia on the vasodilator activity of nifedipine and evidence of secondary pharmacological properties
40. Statins as anti-pyroptotic agents.
41. A Systematic Review of Published Physiologically-based Kinetic Models and an Assessment of their Chemical Space Coverage.
42. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).
43. Effects of statins on myocarditis: A review of underlying molecular mechanisms.
44. How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.
45. Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
46. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
47. Extreme cardiovascular risk—do we need a new risk category?
48. Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacology.
49. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
50. Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.